Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.

OBJECTIVE: To estimate the impact of cotrimoxazole prophylaxis on the survival of human immunodeficiency virus (HIV)-positive tuberculosis (TB) patients. METHODS: A cohort study with a historical comparison group was conducted. End-of-treatment outcomes and 18-month survival were compared between TB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mwaungulu, Frank B. D., Floyd, Sian, Crampin, Amelia C., Kasimba, Simplex, Malema, Simon, Kanyongoloka, Huxley, Harries, Anthony D., Glynn, Judith R., Fine, Paul E. M.
Format: Artigo
Idioma:Inglês
Publicat: World Health Organization 2004
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2622842/
https://ncbi.nlm.nih.gov/pubmed/15298226
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars